Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

FRANCIA

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).

APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

Service de Neurologie 2 : Unité d'Onco-Neurologie

Ulteriori dettagli

FRANCIA

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma

APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

Service de Neurologie 2 : Unité d'Onco-Neurologie

Ulteriori dettagli

FRANCIA

ILE-DE-FRANCE
PARIS

Study of temozolomide-Bcnu association before radiotherapy in anaplastic oligodendroglioma (Phase II)

APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

Service de Neurologie 2 : Unité d'Onco-Neurologie

Ulteriori dettagli

FRANCIA

ILE-DE-FRANCE
PARIS

Methotrexate-temozolomide association in cerebral primary lymphoma (Phase II)

APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

Service de Neurologie 2 : Unité d'Onco-Neurologie

Ulteriori dettagli

FRANCIA

ILE-DE-FRANCE
PARIS

Radiation therapy and concurrent plus adjuvant Temsirolimus (CCI-779) versus chemo-irradiation with Temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter - a randomized multicenter, open-label, Phase II study - FR

APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

Service de Neurologie 2 : Unité d'Onco-Neurologie

Ulteriori dettagli